ZymoGenetics, Inc. (NASDAQ:ZGEN.DL)

CAPS Rating: No stars

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Recs

0
Player Avatar ignacito (< 20) Submitted: 4/20/2010 1:19:03 PM : Outperform Start Price: $6.31 ZGEN.DL Score: +57.80

f

Report this Post Reply

Featured Broker Partners


Advertisement